NSPR InspireMD Inc.
$0.47▲ +2.86%
Healthcare
Other
Volume 524.8K
Avg Volume (10D) 277.1K
Key Metrics & Fundamentals
Market Cap
$21.76M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.43 - 2.41
% vs 50 MA
-31.42%
% vs 200 MA
-56.73%
RSI-14
32.5
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.89
Free Cash Flow
-$11.23M
Gross Rev
$1.77M
Gross Profit
-$774,000
EBITDA
-$14.29M
COGS
$2.55M
Operating Exp
$13.67M
Operating Income
-$14.45M
EBIT
-$14.45M
Pretax Income
-$14.32M
Net Income
-$14.32M
EPS (Diluted)
-0.17
Price & Volume History
Loading chart…
Recent News
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
GlobeNewswire · Sep 21, 2026 9:00 AM ET
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Sep 4, 2026 4:01 PM ET
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 3, 2026 8:00 AM ET
InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
Zacks · Aug 20, 2026 12:00 PM ET
InspireMD Inc (NSPR) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges While ...
GuruFocus.com · Aug 17, 2026 4:28 PM ET
InspireMD, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 17, 2026 12:51 PM ET
InspireMD Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 17, 2026 7:00 AM ET
InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 14, 2026 6:55 PM ET
InspireMD to Announce Second Quarter 2026 Financial Results
GlobeNewswire · Aug 10, 2026 4:01 PM ET
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Aug 7, 2026 4:01 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See NSPR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.